Interestingly, the increased levels of an anti-cancer cytokine, IL-2, are significant for treating metastatic cancers by inhibiting tumor growth via the activation of lymphocytes (Sun et al. 2018). The gene discussed is IL2; the disease is metastatic malignant neoplasm.